Lung cancer
Symposium
Precision medicine approaches in lung cancer
Clinical
Basic translational science
Aims : To present the recent developments in our understanding of the pathogenesis and precision therapy of lung cancer. The symposium will focus in particular on signalling and the immunological and genetic alterations in lung cancer.
Target audience :
Allied health professional, Clinician, General practitioner, Immunologist, Junior member, Nurse, Oncologist, Pathologist, Patient, Pharmaceutical industry representative, Psychologist, Pulmonologist, Radiologist, Researcher, Resident, Respiratory physician, Scientist, Student, Thoracic endoscopist, Thoracic surgeon, Trainee
14:45
What can we learn from the biology of premalignant neoplasia for cancer prevention?
A. Spira(Boston, United States)
COI
1
2883
15:15
Molecular pathology and precision medicine for lung cancer
G. Rossi(Ravenna, Italy)
COI
2
2884
15:45
Precision medicine for lung cancer: new targeted treatments
T. Berghmans(Bruxelles, Belgium)
COI
3
2885
16:15
Genetic heterogeneity and neoantigens in lung cancer: implications for next-generation immunotherapy
T. Wehler(Homburg (Saar), Germany)
COI
4
2886
. . .
